The NABOTA Vision

Daewoong Pharmaceutical announced its vision for ‘NABOTA’ sweeping the global botulinum toxin market

- A large-scale press conference was held to announce domestic roll-out of NABOTA and global vision on April 16

- NABOTA has reached a milestone of KRW 700 billion in cumulative export sales, poised to hit the record high exports in domestic pharmaceutical industry

- CEO and other high-ranking officials of U.S.-based Evolus visited Korea and put forward blueprint for NABOTA making a clean sweep of U.S. and European market 

Daewoong Pharmaceutical's NABOTA®, sets foot in the Philippines

NABOTA®, is the latest Clostridium Botulinum Toxin Type A that boasts of High Purity which makes it safe. Its stability leads to longer shelf life. Compared to the existing brands, NABOTA® has faster effect and longer duration. Developed from bio-technology of over 30 years of know-how and manufactured from Daewoong’s world class GMP, NABOTA® is widely accepted to more than 90 countries worldwide including US and European Union nations.

The NABOTA® Philippine Launch was actually historic as this is the first time that all 7 societies from the field of aesthetic medicine (Phil. Dermatological Society, Phil. Academy of Dermatologic Surgery Foundation, Phil. Assn. of Plastic and Reconstructive Surgery, Phil. Academy of Clinical & Cosmetic Dermatology, Phil. Academy of Aesthetic and Age-Management Medicine Inc., Phil. Association of Primary Skin Health Physicians, Inc., Phil. Academy of Aesthetic Surgery) supported the event alongside more than 500 doctors.

Daewoong Pharmaceutical Co., Ltd. has the largest prescription drug sales in Korea and envisions itself to become a top 50 global healthcare company for 2015.

In the Philippines, NABOTA® is exclusively marketed by Daewoong Pharma Phils. Inc. under the leadership of its experienced Brand Manager Christopher Cachuela who has been promoting dermatology products for more than 10 years. Daewoong Phils has successfully registered and launched over 37 brands in the market.
With NABOTA® entering the Philippine market, Filipinos can now achieve natural beauty safely and effectively.

Chris Cachuela Launches Nabota in the Philippines

Today, Nabota is widely used in different countries. Daewoong Pharma has successfully closed a series of contracts to export Nabota to the United States, Latin America, and Middle East countries. What’s more, the Daewoong Pharma has built the cooperation system with global pharma companies to achieve its goal of exporting Nabota to more than 90 countries including Canada and Asian countries.

NABOTA® is exclusively marketed by Daewoong Pharma Phils. Inc. under the leadership of its experienced Brand Manager Christopher Cachuela who has been promoting dermatology products for more than 10 years. Daewoong Phils has successfully registered and launched over 37 brands in the Philippines.

NABOTA High Purity Toxin

Daewoong revolutionized the production of botulinum toxin through a patented process. NABOTA® was produced in a Good Manufacturing Practice (GMP) facility to ensure that we deliver the highest quality of botulinum toxin possible.

NABOTA®  secured the international standard quality through the own process with the latest patent

NABOTA®  is being produced in a GMP ^† approved facility.

NABOTA® is composed of 100% botulinum toxin complex NABOTA® is a product with high purity with NO impurities.

For more info visit our website www.nabota.info

Or send us an email nabota.ph@gmail.com